Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-30

FDA Approved: ATOMOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s original ANDA for atomoxetine, establishing a generic version of the ADHD medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

ORIG AP for ATOMOXETINE (ATOMOXETINE)